<DOC>
	<DOCNO>NCT00694460</DOCNO>
	<brief_summary>This study evaluate safety immunogenicity rabies vaccine Japanese encephalitis vaccine toddler . All child develop adequate immune response . Rabies vaccination PCECV interfere antibody response Japanese encephalitis vaccine . The rabies vaccine PCECV Japanese encephalitis vaccine safe immunogenic administer concomitantly toddler .</brief_summary>
	<brief_title>Evalution Immunogenicity , Safety Booster Response Rabies Vaccine Administered Concomitantly With Japanese Encephalitis Vaccine Toddlers</brief_title>
	<detailed_description />
	<mesh_term>Encephalitis</mesh_term>
	<mesh_term>Encephalitis , Japanese</mesh_term>
	<mesh_term>Rabies</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Male female 1218 month old toddler good health time entry study available visit schedule study grant write informed consent , sign parent history rabies immunization history Japanese encephalitis immunization disease significant acute chronic infectious disease time enrollment fever ≥ 38.0°C ( axillary ) or/and significant acute chronic infection require antibiotic antiviral therapy within past 7 day enrollment treatment corticosteroid , immunosuppressive drug specific antiinflammatory drug take chloroquine two month period enrollment administration vaccine within past 14 day enrollment know immunodeficiency autoimmune disease history allergy egg , egg product know hypersensitivity neomycin , tetracycline , amphotericinB plan surgery study period enrol investigational trial contemporaneously family plan leave area study site end study period history febrile convulsion history wheeze</criteria>
	<gender>All</gender>
	<minimum_age>12 Months</minimum_age>
	<maximum_age>18 Months</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>rabies vaccination</keyword>
	<keyword>pre-exposure prophylaxis</keyword>
	<keyword>rabies virus neutralize antibody</keyword>
</DOC>